|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 35/17 | (2015.01) |
| A61K 38/17 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K 14/725 | (2006.01) |
| (11) | Patento numeris | 3845557 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20208043.8 |
| Europos patento paraiškos padavimo data | 2016-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201562175003 P | 2015-06-12 | US |
| (72) |
DROPULIC, Boro , US
ORENTAS, Rimas , US
SCHNEIDER, Dina , US
KRUEGER, Winfried , US
|
| (73) |
Lentigen Technology, Inc. ,
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878,
US
|
| (54) | METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |
| METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |